Akero Therapeutics Inc (AKRO)
18.96
-1.30
(-6.42%)
USD |
NASDAQ |
Apr 25, 11:31
Akero Therapeutics Total Assets (Quarterly): 580.27M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 580.27M |
| September 30, 2023 | 635.33M |
| June 30, 2023 | 663.81M |
| March 31, 2023 | 348.82M |
| December 31, 2022 | 356.57M |
| September 30, 2022 | 379.41M |
| June 30, 2022 | 185.68M |
| March 31, 2022 | 169.89M |
| December 31, 2021 | 195.55M |
| September 30, 2021 | 223.53M |
| June 30, 2021 | 238.01M |
| Date | Value |
|---|---|
| March 31, 2021 | 257.62M |
| December 31, 2020 | 273.34M |
| September 30, 2020 | 300.04M |
| June 30, 2020 | 114.06M |
| March 31, 2020 | 126.62M |
| December 31, 2019 | 138.12M |
| September 30, 2019 | 150.14M |
| June 30, 2019 | 163.17M |
| March 31, 2019 | 72.07M |
| December 31, 2018 | 77.15M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
114.06M
Minimum
Jun 2020
663.81M
Maximum
Jun 2023
289.47M
Average
238.01M
Median
Jun 2021
Total Assets (Quarterly) Benchmarks
| Madrigal Pharmaceuticals Inc | 640.55M |
| 89bio Inc | 596.27M |
| Viking Therapeutics Inc | 368.49M |
| Eli Lilly and Co | 64.01B |
| Ionis Pharmaceuticals Inc | 2.990B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 44.96M |
| Shareholders Equity (Quarterly) | 535.31M |